Sam Azoulay
Patrimonio netto: 949 326 $ in data 31/07/2026
Patrimonio netto: 949 326 $ in data 31/07/2026
Salomon Azoulay currently works at MBX Biosciences, Inc., as Chief Medical Officer from 2024.
Dr. Azoulay also formerly worked at Pfizer Essential Health, as Chief Medical Officer from 2013 to 2018, Sumitomo Pharma UK Holdings Ltd., as Chief Medical Officer from 2021 to 2023, and Roivant Sciences, Inc., as Chief Medical Officer from 2018 to 2020.
Dr. Azoulay received his undergraduate degree and doctorate degree from Sorbonne Université.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 04/08/2026 | 14.399 ( 0,03% ) | 949 326 $ | 31/07/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| MBX BIOSCIENCES, INC. | Direttore Tecnico/Scientifico/R&S | 01/06/2024 |
| Società | Posizione | Fine |
|---|---|---|
Sumitomo Pharma UK Holdings Ltd.
Sumitomo Pharma UK Holdings Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company with interests in provides biopharmaceutical services | Direttore Tecnico/Scientifico/R&S | 01/07/2023 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs | Direttore Tecnico/Scientifico/R&S | 01/12/2020 |
Pfizer Essential Health
Pfizer Essential Health Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Direttore Tecnico/Scientifico/R&S | 01/05/2018 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
Sorbonne Université
Sorbonne Université Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pfizer Essential Health
Pfizer Essential Health Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs | Health Technology |
MBX Biosciences, Inc.
MBX Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company focused on discovery and development of novel precision peptide therapies for endocrine & metabolic disorders | Health Technology |
Sumitomo Pharma UK Holdings Ltd.
Sumitomo Pharma UK Holdings Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company with interests in provides biopharmaceutical services | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale